Ohr Pharmaceutical Inc.
8Patents
8Active
8Granted
43Portfolio score
Filing activity: Mar 21, 2005 → Mar 12, 2019 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7981876B2 | Polymorphic and amorphous salt forms of squalamine dilactate | Chemistry; Metallurgy | 7 | Active |
| US9365608B2 | Method for treating diabetes | Chemistry; Metallurgy | 6 | Active |
| US9546194B2 | Aminosteroids for the treatment of a PTP1B associated disease | Chemistry; Metallurgy | 5 | Active |
| US7728157B2 | Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols | Chemistry; Metallurgy | 1 | Active |
| US8084239B2 | Preparation of a therapeutic composition | Emerging Cross-Sectional Technologies | 0 | Active |
| US10556923B2 | Aminosteroids for the treatment of a PTP1B associated disease | Chemistry; Metallurgy | 0 | Active |
| US8716270B2 | Polymorphic and amorphous salt forms of squalamine dilactate | Chemistry; Metallurgy | 0 | Active |
| US8987236B2 | Therapeutic uses for an aminosterol compound | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.